Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 200

The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.

Hypertriglyceridemia secondary to obesity and diabetes

Subramanian, Savitha, Chait, Alan · 2012 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.bbalip.2011.10.003

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 33 references

Research works printed but not linked: 71

  1. Carroll, 2005, Trends in serum lipids and lipoproteins of adults, 1960–2002, JAMA, 294, 1773, 10.1001/jama.294.14.1773 · DOI · Paper page
  2. D'Agostino, 2004, Cardiovascular disease risk factors predict the development of type 2 diabetes: the insulin resistance atherosclerosis study, Diabetes Care, 27, 2234, 10.2337/diacare.27.9.2234 · DOI
  3. Resnick, 2006, Achievement of American Diabetes Association clinical practice recommendations among U.S. adults with diabetes, 1999–2002: the National Health and Nutrition Examination Survey, Diabetes Care, 29, 531, 10.2337/diacare.29.03.06.dc05-1254 · DOI · Paper page
  4. Brunzell, 1976, Myocardial infarction in the familial forms of hypertriglyceridemia, Metabolism, 25, 313, 10.1016/0026-0495(76)90089-5 · DOI · Paper page
  5. Hopkins, 2003, Coronary artery disease risk in familial combined hyperlipidemia and familial hypertriglyceridemia: a case–control comparison from the National Heart, Lung, and Blood Institute Family Heart Study, Circulation, 108, 519, 10.1161/01.CIR.0000081777.17879.85 · DOI · Paper page
  6. Goldberg, 2011, Triglycerides and heart disease: still a hypothesis?, Arterioscler. Thromb. Vasc. Biol., 31, 1716, 10.1161/ATVBAHA.111.226100 · DOI · Paper page
  7. Ginsberg, 2000, Insulin resistance and cardiovascular disease, J. Clin. Invest., 106, 453, 10.1172/JCI10762 · DOI · Paper page
  8. Zierath, 1998, Regional difference in insulin inhibition of non-esterified fatty acid release from human adipocytes: relation to insulin receptor phosphorylation and intracellular signalling through the insulin receptor substrate-1 pathway, Diabetologia, 41, 1343, 10.1007/s001250051075 · DOI · Paper page
  9. Kissebah, 1982, Relation of body fat distribution to metabolic complications of obesity, J. Clin. Endocrinol. Metab., 54, 254, 10.1210/jcem-54-2-254 · DOI · Paper page
  10. Seidell, 1988, Abdominal fat depots measured with computed tomography: effects of degree of obesity, sex, and age, Eur. J. Clin. Nutr., 42, 805
  11. Lewis, 2002, Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes, Endocr. Rev., 23, 201, 10.1210/er.23.2.201 · DOI
  12. Lewis, 1997, Fatty acid regulation of very low density lipoprotein production, Curr. Opin. Lipidol., 8, 146, 10.1097/00041433-199706000-00004 · DOI · Paper page
  13. Chan, 2002, Apolipoprotein B-100 kinetics in visceral obesity: associations with plasma apolipoprotein C-III concentration, Metabolism, 51, 1041, 10.1053/meta.2002.33339 · DOI
  14. Mauriege, 1995, Regional variation in adipose tissue metabolism of severely obese premenopausal women, J. Lipid Res., 36, 672, 10.1016/S0022-2275(20)40053-7 · DOI
  15. Byrne, 1995, Decreased non-esterified fatty acid suppression and features of the insulin resistance syndrome occur in a sub-group of individuals with normal glucose tolerance, Diabetologia, 38, 1358, 10.1007/BF00401770 · DOI
  16. Sadur, 1984, Insulin responsiveness of adipose tissue lipoprotein lipase is delayed but preserved in obesity, J. Clin. Endocrinol. Metab., 59, 1176, 10.1210/jcem-59-6-1176 · DOI
  17. Ginsberg, 2009, The ever-expanding role of degradation in the regulation of apolipoprotein B metabolism, J. Lipid Res., 50, S162, 10.1194/jlr.R800090-JLR200 · DOI · Paper page
  18. Verges, 2010, Abnormal hepatic apolipoprotein B metabolism in type 2 diabetes, Atherosclerosis, 211, 353, 10.1016/j.atherosclerosis.2010.01.028 · DOI
  19. Kissebah, 1982, Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein-B kinetics in non-insulin-dependent diabetes mellitus, Diabetes, 31, 217, 10.2337/diabetes.31.3.217 · DOI
  20. Vedala, 2006, Delayed secretory pathway contributions to VLDL-triglycerides from plasma NEFA, diet, and de novo lipogenesis in humans, J. Lipid Res., 47, 2562, 10.1194/jlr.M600200-JLR200 · DOI
  21. Matsubara, 2002, Decreased plasma adiponectin concentrations in women with dyslipidemia, J. Clin. Endocrinol. Metab., 87, 2764, 10.1210/jc.87.6.2764 · DOI · Paper page
  22. Lara-Castro, 2006, Adiponectin multimeric complexes and the metabolic syndrome trait cluster, Diabetes, 55, 249, 10.2337/diabetes.55.01.06.db05-1105 · DOI · Paper page
  23. Neumeier, 2007, High molecular weight adiponectin reduces apolipoprotein B and E release in human hepatocytes, Biochem. Biophys. Res. Commun., 352, 543, 10.1016/j.bbrc.2006.11.058 · DOI
  24. Qiao, 2008, Adiponectin reduces plasma triglyceride by increasing VLDL triglyceride catabolism, Diabetes, 57, 1824, 10.2337/db07-0435 · DOI · Paper page
  25. Ginsberg, 2006, Metabolic syndrome: focus on dyslipidemia, Obesity (Silver Spring), 14, 41S, 10.1038/oby.2006.281 · DOI · Paper page
  26. Adiels, 2005, Overproduction of VLDL1 driven by hyperglycemia is a dominant feature of diabetic dyslipidemia, Arterioscler. Thromb. Vasc. Biol., 25, 1697, 10.1161/01.ATV.0000172689.53992.25 · DOI · Paper page
  27. Schneeman, 1993, Relationships between the responses of triglyceride-rich lipoproteins in blood plasma containing apolipoproteins B-48 and B-100 to a fat-containing meal in normolipidemic humans, Proc. Natl. Acad. Sci. U. S. A., 90, 2069, 10.1073/pnas.90.5.2069 · DOI · Paper page
  28. Federico, 2006, Diabetes, 55, 1316, 10.2337/db04-1084 · DOI
  29. Annuzzi, 2008, Postprandial chylomicrons and adipose tissue lipoprotein lipase are altered in type 2 diabetes independently of obesity and whole-body insulin resistance, Nutr. Metab. Cardiovasc. Dis., 18, 531, 10.1016/j.numecd.2007.12.003 · DOI · Paper page
  30. Beigneux, 2010, GPIHBP1 and the processing of triglyceride-rich lipoproteins, Clin. Lipidol., 5, 575, 10.2217/clp.10.43 · DOI
  31. 1992, Lipid and lipoprotein levels in patients with IDDM diabetes control and complication. Trial experience. The DCCT Research Group, Diabetes Care, 15, 886, 10.2337/diacare.15.7.886 · DOI
  32. Weidman, 1982, Effects of insulin on plasma lipoproteins in diabetic ketoacidosis: evidence for a change in high density lipoprotein composition during treatment, J. Lipid Res., 23, 171, 10.1016/S0022-2275(20)38186-4 · DOI
  33. Purnell, 1998, Effect of excessive weight gain with intensive therapy of type 1 diabetes on lipid levels and blood pressure: results from the DCCT. Diabetes Control and Complications Trial, JAMA, 280, 140, 10.1001/jama.280.2.140 · DOI · Paper page
  34. Purnell, 2003, Relationship of family history of type 2 diabetes, hypoglycemia, and autoantibodies to weight gain and lipids with intensive and conventional therapy in the Diabetes Control and Complications Trial, Diabetes, 52, 2623, 10.2337/diabetes.52.10.2623 · DOI
  35. Verges, 2009, Lipid disorders in type 1 diabetes, Diab. Metab., 35, 353, 10.1016/j.diabet.2009.04.004 · DOI
  36. Lewis, 1991, Postprandial triglyceride response in type 1 (insulin-dependent) diabetes mellitus is not altered by short-term deterioration in glycaemic control or level of postprandial insulin replacement, Diabetologia, 34, 253, 10.1007/BF00405084 · DOI
  37. Guy, 2009, Lipid and lipoprotein profiles in youth with and without type 1 diabetes: the SEARCH for Diabetes in Youth case–control study, Diabetes Care, 32, 416, 10.2337/dc08-1775 · DOI · Paper page
  38. Jenkins, 2003, Lipoproteins in the DCCT/EDIC cohort: associations with diabetic nephropathy, Kidney Int., 64, 817, 10.1046/j.1523-1755.2003.00164.x · DOI · Paper page
  39. Mattock, 2001, Plasma lipids and urinary albumin excretion rate in Type 1 diabetes mellitus: the EURODIAB IDDM Complications Study, Diabet. Med., 18, 59, 10.1046/j.1464-5491.2001.00411.x · DOI
  40. Rashid, 2003, Mechanisms of HDL lowering in insulin resistant, hypertriglyceridemic states: the combined effect of HDL triglyceride enrichment and elevated hepatic lipase activity, Clin. Biochem., 36, 421, 10.1016/S0009-9120(03)00078-X · DOI · Paper page
  41. Nicoll, 1980, Evaluation of the roles of lipoprotein lipase and hepatic lipase in lipoprotein metabolism: in vivo and in vitro studies in man, Eur. J. Clin. Invest., 10, 487, 10.1111/j.1365-2362.1980.tb02090.x · DOI
  42. Packard, 1997, Lipoprotein heterogeneity and apolipoprotein B metabolism, Arterioscler. Thromb. Vasc. Biol., 17, 3542, 10.1161/01.ATV.17.12.3542 · DOI · Paper page
  43. Galeano, 1998, Small dense low density lipoprotein has increased affinity for LDL receptor-independent cell surface binding sites: a potential mechanism for increased atherogenicity, J. Lipid Res., 39, 1263, 10.1016/S0022-2275(20)32551-7 · DOI · Paper page
  44. Galeano, 1994, Apoprotein B structure and receptor recognition of triglyceride-rich low density lipoprotein (LDL) is modified in small LDL but not in triglyceride-rich LDL of normal size, J. Biol. Chem., 269, 511, 10.1016/S0021-9258(17)42379-9 · DOI · Paper page
  45. Zheng, 2010, Apolipoprotein C-III and the metabolic basis for hypertriglyceridemia and the dense low-density lipoprotein phenotype, Circulation, 121, 1722, 10.1161/CIRCULATIONAHA.109.875807 · DOI · Paper page
  46. Austin, 1988, Low-density lipoprotein subclass patterns and risk of myocardial infarction, JAMA, 260, 1917, 10.1001/jama.1988.03410130125037 · DOI · Paper page
  47. Bjornheden, 1996, Accumulation of lipoprotein fractions and subfractions in the arterial wall, determined in an in vitro perfusion system, Atherosclerosis, 123, 43, 10.1016/0021-9150(95)05770-6 · DOI · Paper page
  48. de Graaf, 1991, Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects, Arterioscler. Thromb., 11, 298, 10.1161/01.ATV.11.2.298 · DOI · Paper page
  49. Tribble, 2001, Enhanced oxidative susceptibility and reduced antioxidant content of metabolic precursors of small, dense low-density lipoproteins, Am. J. Med., 110, 103, 10.1016/S0002-9343(00)00700-2 · DOI · Paper page
  50. Taskinen, 1987, Alcohol-induced changes in serum lipoproteins and in their metabolism, Am. Heart J., 113, 458, 10.1016/0002-8703(87)90614-4 · DOI · Paper page
  51. Chait, 1981, Chylomicronemia syndrome in diabetes mellitus, Diabetes Care, 4, 343, 10.2337/diacare.4.3.343 · DOI
  52. Chait, 1992, Chylomicronemia syndrome, Adv. Intern. Med., 37, 249
  53. Havel, 1969, Pathogenesis, differentiation and management of hypertriglyceridemia, Adv. Intern. Med., 15, 117
  54. Kahn, 2003, Metabolic risks identified by the combination of enlarged waist and elevated triacylglycerol concentration, Am. J. Clin. Nutr., 78, 928, 10.1093/ajcn/78.5.928 · DOI · Paper page
  55. Kanaley, 2001, Abdominal fat distribution in pre- and postmenopausal women: the impact of physical activity, age, and menopausal status, Metabolism, 50, 976, 10.1053/meta.2001.24931 · DOI
  56. Donnelly, 2003, Effects of a 16-month randomized controlled exercise trial on body weight and composition in young, overweight men and women: the Midwest Exercise Trial, Arch. Intern. Med., 163, 1343, 10.1001/archinte.163.11.1343 · DOI · Paper page
  57. Ross, 1996, Influence of diet and exercise on skeletal muscle and visceral adipose tissue in men, J. Appl. Physiol., 81, 2445, 10.1152/jappl.1996.81.6.2445 · DOI · Paper page
  58. Duncan, 2005, Prescribing exercise at varied levels of intensity and frequency: a randomized trial, Arch. Intern. Med., 165, 2362, 10.1001/archinte.165.20.2362 · DOI · Paper page
  59. Thomas, 2000, Preferential loss of visceral fat following aerobic exercise, measured by magnetic resonance imaging, Lipids, 35, 769, 10.1007/s11745-000-0584-0 · DOI
  60. Williamson, 1992, Weight loss attempts in adults: goals, duration, and rate of weight loss, Am. J. Public Health, 82, 1251, 10.2105/AJPH.82.9.1251 · DOI · Paper page
  61. Colhoun, 2004, Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial, Lancet, 364, 685, 10.1016/S0140-6736(04)16895-5 · DOI · Paper page
  62. Dane-Stewart, 2003, Effect of atorvastatin on apolipoprotein B48 metabolism and low-density lipoprotein receptor activity in normolipidemic patients with coronary artery disease, Metabolism, 52, 1279, 10.1016/S0026-0495(03)00281-6 · DOI
  63. Keech, 2005, Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial, Lancet, 366, 1849, 10.1016/S0140-6736(05)67667-2 · DOI · Paper page
  64. Kamanna, 2000, Mechanism of action of niacin on lipoprotein metabolism, Curr. Atheroscler. Rep., 2, 36, 10.1007/s11883-000-0093-1 · DOI
  65. Elam, 2000, Effect of niacin on lipid and lipoprotein levels and glycemic control in patients with diabetes and peripheral arterial disease: the ADMIT study: a randomized trial. Arterial Disease Multiple Intervention Trial, JAMA, 284, 1263, 10.1001/jama.284.10.1263 · DOI · Paper page
  66. Goldberg, 2005, A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia, Diabetes Care, 28, 1547, 10.2337/diacare.28.7.1547 · DOI · Paper page
  67. Hsiao, 2004, Variance-modeled posterior inference of microarray data: detecting gene-expression changes in 3T3-L1 adipocytes, Bioinformatics, 20, 3108, 10.1093/bioinformatics/bth371 · DOI
  68. Nicholls, 2010, J. Am. Coll. Cardiol., 57, 153, 10.1016/j.jacc.2010.06.055 · DOI
  69. Dormandy, 2005, Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial, Lancet, 366, 1279, 10.1016/S0140-6736(05)67528-9 · DOI · Paper page
  70. Lewis, 2011, Risk of bladder cancer among diabetic patients treated with pioglitazone: interim report of a longitudinal cohort study, Diabetes Care, 34, 916, 10.2337/dc10-1068 · DOI · Paper page
  71. Nissen, 2011, Rosiglitazone revisited: an updated meta-analysis of risk for myocardial infarction and cardiovascular mortality, Arch. Intern. Med., 170, 1191, 10.1001/archinternmed.2010.207 · DOI · Paper page

Cited by

See all 200

Metadata

Authors
Subramanian, S., & Chait, A.
Venue
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
Publisher
Elsevier BV
Published
2012-05
Volume
1821
Issue
5
Pages
819-825
ISSN
1388-1981 (ISSN-L)
OpenAlex
W2083230171
Cited by
200
References
33
FWCI
7.18
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Hypertriglyceridemia secondary to obesity and diabetes. https://app.cochat.ai/papers/10.1016/j.bbalip.2011.10.003
The paper
Subramanian, S., & Chait, A. (2012). Hypertriglyceridemia secondary to obesity and diabetes. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. https://doi.org/10.1016/j.bbalip.2011.10.003

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.